IFPMA CLINICAL TRIALS PORTAL
IFPMA Clinical Trials Portal is brought to you by IFPMA on behalf of its Member Companies and Associations. IFPMA Clinical Trials Portal ensures: -A free and easy-to-use interface for patients and health professionals alike to ongoing clinical trials, clinical trial results and complementary information on related issues. -Non-promotional and reliable information. -Industry's commitment to the transparency of clinical trials. Basic Search Features: -Search by Medical Condition and Drug... Name -Language Interfaces (En, Es, Fr, De, Jp) -Glossary and Easy Explanation of Medical Expressions -Geographical Search Myportal: -Create and save up to six search queries -Repeat these queries whenever you wish -Receive an e-mail alert when a new matching trial is posted Key Documents: -Newsletter -Press Releases -Joint position on the Disclosure of Clinical Trial Information -Useful Tips -Video Tour -FAQs -Pediatric FAQs -Glossary
IFPMA CLINICAL TRIALS PORTAL
Industry:
Search Engine
Address:
Geneva, Geneve, Switzerland
Country:
Switzerland
Website Url:
http://www.clinicaltrials.ifpma.org
Total Employee:
1+
Status:
Closed
Contact:
+41223383200
Email Addresses:
[email protected]
Official Site Inspections
http://www.clinicaltrials.ifpma.org
Unable to get host informations!!!
More informations about "IFPMA Clinical Trials Portal"
ClinicalTrials.gov
Glossary. Study record managers: refer to the Data Element Definitions if submitting registration or results information.. Search for termsSee details»
The road to strengthening clinical trials - International Federation …
The road to strengthening clinical trials Ifpma.org | 5 A stronger clinical trials ecosystem Building on and coming off the lessons learned from the COVID-19 pandemic, which highlighted the …See details»
IFPMA - Innovating to improve health worldwide
Value of investment on NCDs: Impact on health outcomes in low- and middle-income countries. In new research commissioned by IFPMA, Airfinity has determined that an additional investment …See details»
First WHO Global Clinical Trials Forum puts forward a …
Nov 29, 2023 Engaging clinical practitioners to integrate clinical trials into health systems and practices. The anticipated outcomes from these actions would change the clinical trial landscape with fewer, well-designed trials generating …See details»
International Clinical Trials Registry Platform (ICTRP)
The mission of the WHO International Clinical Trials Registry Platform is to ensure that a complete view of research is accessible to all those involved in health care decision making. This will improve research transparency and will …See details»
International Federation of Pharmaceutical Manufacturers
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) [1] is a trade association that represents internationally over 90 pharmaceutical companies and …See details»
Diversity and Inclusion in Clinical Trials: Bioethical
May 20, 2022 As IFPMA members, we believe that the knowledge gained from clinical trials should be used to support the development and use of innovative medicines, vaccines and other therapies, in order to develop the right …See details»
IFPMA Clinical Trials Portal - Research Information
Jun 1, 2006 The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) has launched the second stage of the IFPMA Clinical Trials Portal. Developed in …See details»
IFPMA Clinical Trials Portal - Crunchbase
IFPMA Clinical Trials Portal is brought to you by IFPMA on behalf of its Member Companies and Associations. IFPMA Clinical Trials Portal ensures: -A free and easy-to-use interface for patients and health professionals alike to ongoing …See details»
Clinical Trials Portal Unveiled - CIO Insight
Sep 22, 2005 The IFPMA portal represents a combined effort by pharmaceutical industry technical and regulatory experts, as well as IBM consultants and currently contains more that …See details»
The Egyptian clinical trials’ registry profile: Analysis of three trial ...
Most studies were performed in universities and sponsored by university/organization, industry or individual researchers. Inclusion of adults from both genders predominated. The median …See details»
(PDF) The Egyptian Clinical Trials’ registry profile: analysis of three ...
The Egyptian Clinical Trials’ registry profile: analysis of three trial registries (International Clinical Trials Registry Platform, Pan-African Clinical Trials Registry and clinicaltrials.gov ...See details»
IFPMA Recommendations: Regulatory agilities applied to clinical …
CLINICAL TRIAL REGULATORY GUIDANCE DURING COVID-19 - ICMRA HEALTH AUTHORITIES. May 2021 • IFPMA. Letter to ICMRA - Clinical Trial agilities. May 2021 • PAN …See details»
CLINICAL TRIALS PORTAL LAUNCHED BY IFPMA | FDAnews
The IFPMA Clinical Trials Portal is the first Internet search engine constructed specifically to link to online information made available by the pharmaceutical industry about clinical trials …See details»
Novartis receives third FDA approval for oral Fabhalta® (iptacopan ...
3 days ago In particular, our expectations regarding such products could be affected by, among other things, the uncertainties inherent in research and development, including clinical trial …See details»
IFPMA Principles for Responsible Clinical Trial Data Sharing
International Ch. Des Mines 9 Tel: +41 22 338 32 00 Federation of P.O. Box 195 Fax: +41 22 338 32 99 Pharmaceutical 1211 Geneva 20 www.ifpma.org Manufacturers & Switzerland …See details»
Novartis oral Fabhalta® (iptacopan) receives positive CHMP …
Feb 28, 2025 ClinicalTrials.gov. NCT05268289. An Adaptive, Randomized, Double-Blind, Dose Exploration, Parallel Group, Placebo Controlled, Multicenter Phase 2 Trial to Evaluate the …See details»
Clinical trials: Ethics, innovation, and how to achieve greater
May 20, 2023 Clinical trials are a vital component of drug development, but the persistent issues of inequity and inequality pose significant ethical, social, and economic challenges. The lack of …See details»
U.S. FDA approves TREMFYA® (guselkumab), the first and only IL …
4 days ago TREMFYA® is the only IL-23i to demonstrate clinical remission and endoscopic response, both at one year, with a fully subcutaneous induction regimen Supported by data …See details»
Ushering in a new era for cancer therapy - IFPMA
Aug 28, 2023 We pursue diversity in clinical trials, knowing that, among other characteristics, age, race, and ethnic background can sometimes determine how a potential treatment works …See details»